stars 1 stars 2 stars 3

First of all, we thank you for visiting PHIL Inter Pharma. PHIL Inter Pharma was established in 2004 by PHIL International, a leading exporter of pharmaceutical products in Korea. Starting with Softgel and Cream & Ointment production, we have been constantly growing by expanding to Cephalosporin Antibiotics Powder for injection, Hard capsule, Dry syrup and Dietary supplement Softgel production with dedicated buildings respectively. Korea, we successfully received K-GMP accreditation for the same lines and systems. Southeast Asia, the Middle East and Latin America. We still have a long way to go, but our journey will never end until we become a second to none manufacturer in the Softgel industry!

PHIL Inter Pharma USA Questions

The PHIL Inter Pharma USA annual revenue was $6.9 million in 2026.

10 people are employed at PHIL Inter Pharma USA.

The NAICS codes for PHIL Inter Pharma USA are [325, 32, 32541, 3254].

The SIC codes for PHIL Inter Pharma USA are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users